BrightAccountsProduction v1.0.0 v1.0.0 2023-03-01 The company was dormant during the period Unaudited Accounts The provision of health care, education, cultural and other social services 20 November 2024 0 NI676112 2024-02-29 NI676112 2023-02-28 NI676112 2023-03-01 2024-02-29 NI676112 uk-bus:PrivateLimitedCompanyLtd 2023-03-01 2024-02-29 NI676112 uk-curr:PoundSterling 2023-03-01 2024-02-29 NI676112 uk-bus:AbridgedAccounts 2023-03-01 2024-02-29 NI676112 uk-bus:EntityNoLongerTradingButTradedInPast 2023-03-01 2024-02-29 NI676112 uk-core:ShareCapital 2024-02-29 NI676112 uk-core:TotalEquityAttributableToOwnersParentBeforeNon-controllingInterests 2024-02-29 NI676112 uk-bus:FRS102 2023-03-01 2024-02-29 NI676112 2023-03-01 2024-02-29 NI676112 uk-bus:Director1 2023-03-01 2024-02-29 NI676112 uk-bus:Director2 2023-03-01 2024-02-29 NI676112 uk-bus:AuditExempt-NoAccountantsReport 2023-03-01 2024-02-29 xbrli:pure iso4217:GBP xbrli:shares
 
 
 
Lumen Healthcare Limited
 
Abridged Unaudited Financial Statements
 
for the financial year ended 29 February 2024



Lumen Healthcare Limited
DIRECTORS' REPORT
for the financial year ended 29 February 2024

 
The directors present their report and the unaudited financial statements for the financial year ended 29 February 2024.
 
The Company is dormant and has not traded during the financial year.
     
Directors
The directors who served during the financial year are as follows:
     
Liam Paul Quigley
Patrick Kieran McGrenaghan
   
There were no changes in shareholdings between 29 February 2024 and the date of signing the financial statements.
     
In accordance with the Constitution, the directors retire by rotation and, being eligible, offer themselves for re-election.
     
Political Contributions
The company did not make any disclosable political donations in the current financial year.
     
Statement of Directors' Responsibilities
     
The directors are responsible for preparing the Directors' Report and the financial statements in accordance with applicable law and regulations.
     
Company law requires the directors to prepare financial statements for each financial year. Under that law the directors have elected to prepare the financial statements in accordance with United Kingdom Generally Accepted Accounting Practice (United Kingdom Accounting Standards and applicable law) including FRS 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" Section 1A (Small Entities). Under company law the directors must not approve the financial statements unless they are satisfied that they give a true and fair view of the state of affairs of the company and of the profit or loss of the company for that period.

In preparing these financial statements, the directors are required to:
- select suitable accounting policies and apply them consistently;
- make judgements and accounting estimates that are reasonable and prudent;
- prepare the financial statements on the going concern basis unless it is inappropriate to presume that the company will continue in business.
     
The directors are responsible for keeping adequate accounting records that are sufficient to show and explain the company's transactions and disclose with reasonable accuracy at any time the financial position of the company and enable them to ensure that the financial statements comply with the Companies Act 2006. They are also responsible for safeguarding the assets of the company and hence for taking reasonable steps for the prevention and detection of fraud and other irregularities.
     
Special provisions relating to small companies
The above report has been prepared in accordance with the special provisions relating to small companies within Part 15 of the Companies Act 2006.
     
     
On behalf of the board
     
     
___________________________
Liam Paul Quigley
Director
     
     
___________________________
Patrick Kieran McGrenaghan
Director
     
20 November 2024



Lumen Healthcare Limited
ABRIDGED PROFIT AND LOSS ACCOUNT
for the financial year ended 29 February 2024
2024
Notes £

Profit for the financial year -
─────────
Total comprehensive income -
    ═════════
The company did not trade during the financial year and received no income and incurred no expenditure. During the financial year the company made neither a profit nor a loss.



Lumen Healthcare Limited
Company Registration Number: NI676112
ABRIDGED BALANCE SHEET
as at 29 February 2024

2024
Notes £
 
Current Assets
Cash and cash equivalents 1,000
─────────
Net Current Assets 1,000
─────────
Total Assets less Current Liabilities 1,000
═════════
 
Capital and Reserves
Called up share capital 1,000
─────────
Equity attributable to owners of the company 1,000
═════════
 
The financial statements have been prepared in accordance with the provisions applicable to companies subject to the small companies' regime and in accordance with the provisions of FRS 102 Section 1A (Small Entities).
       
All of the members have consented to the preparation of abridged accounts in accordance with section 444(2A) of the Companies Act 2006.
For the financial year ended 29 February 2024 the company was entitled to exemption from audit under section 480 of the Companies Act 2006.
       
The directors confirm that the members have not required the company to obtain an audit of its financial statements for the financial year in question in accordance with section 476 of the Companies Act 2006.
       
The directors acknowledge their responsibilities for ensuring that the company keeps accounting records which comply with section 386 and for preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of the financial year and of its profit and loss for the financial year in accordance with the requirements of sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.
       
Approved by the Board and authorised for issue on 20 November 2024 and signed on its behalf by
       
       
________________________________      
Liam Paul Quigley      
Director      
       
       
________________________________
Patrick Kieran McGrenaghan
Director
       



Lumen Healthcare Limited
STATEMENT OF CHANGES IN EQUITY
as at 29 February 2024

Called up Total
share
capital
£ £
 
At 28 February 2023 1,000 1,000
  ───────── ─────────
At 29 February 2024 1,000 1,000
  ═════════ ═════════



Lumen Healthcare Limited
NOTES TO THE ABRIDGED FINANCIAL STATEMENTS
for the financial year ended 29 February 2024

   
1. General Information
 
Lumen Healthcare Limited is a company limited by shares incorporated and registered in Northern Ireland. The registered number of the company is NI676112. The registered office of the company is 75 Prehen Park, Derry, Northern Ireland, BT47 2PB which is also the principal place of business of the company. The provision of health care, education, cultural and other social services The financial statements have been presented in Pound (£) which is also the functional currency of the company.
         
2. Summary of Significant Accounting Policies
 
The following accounting policies have been applied consistently in dealing with items which are considered material in relation to the company's financial statements.
 
Statement of compliance
The financial statements of the company for the financial year ended 29 February 2024 have been prepared in accordance with the provisions of FRS 102 Section 1A (Small Entities) and the Companies Act 2006.
 
Basis of preparation
The financial statements have been prepared on the going concern basis and in accordance with the historical cost convention except for certain properties and financial instruments that are measured at revalued amounts or fair values, as explained in the accounting policies below. Historical cost is generally based on the fair value of the consideration given in exchange for assets.
 
Employee benefits
The company operates a defined contribution pension scheme. The assets of the scheme are held separately from those of the company in an independently administered fund. The company also operates a defined benefit pension scheme for its employees providing benefits based on final pensionable pay. The assets of this scheme are also held separately from those of the company, being invested with pension fund managers.
 
Taxation and deferred taxation
Current tax represents the amount expected to be paid or recovered in respect of taxable profits for the financial year and is calculated using the tax rates and laws that have been enacted or substantially enacted at the Balance Sheet date.

Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date where transactions or events have occurred at that date that will result in an obligation to pay more tax in the future, or a right to pay less tax in the future. Timing differences are temporary differences between the company's taxable profits and its results as stated in the financial statements. Deferred tax is measured on an undiscounted basis at the tax rates that are anticipated to apply in the periods in which the timing differences are expected to reverse, based on tax rates and laws that have been enacted or substantively enacted by the Balance Sheet date.
 
Foreign currencies
Monetary assets and liabilities denominated in foreign currencies are translated at the rates of exchange ruling at the Balance Sheet date. Non-monetary items that are measured in terms of historical cost in a foreign currency are translated at the rates of exchange ruling at the date of the transaction. Non-monetary items that are measured at fair value in a foreign currency are translated using the exchange rates at the date when the fair value was determined. The resulting exchange differences are dealt with in the Profit and Loss Account.
 
Ordinary share capital
The ordinary share capital of the company is presented as equity.
   
3. Statement on previous periods
 
The company did not present financial statements for previous periods.
     
4. Employees
 
The average monthly number of employees, including directors, during the financial year was 0, (2023 - 0).
     
5. Capital commitments
 
The company had no material capital commitments at the financial year-ended 29 February 2024.
   
6. Post-Balance Sheet Events
 
There have been no significant events affecting the company since the financial year-end.